Open Access

Thrombotic and cardiovascular events in HIV infection (Review)

  • Authors:
    • Georgios Dryllis
    • Mavra Vasilopoulou
    • Marianna Politou
    • Achilleas Gerogkiokas
    • Theodoros Pittaras
    • Vassilis Zoumpourlis
    • Demetrios A. Spandidos
    • Argyri Gialeraki
  • View Affiliations

  • Published online on: May 21, 2025     https://doi.org/10.3892/br.2025.2000
  • Article Number: 122
  • Copyright: © Dryllis et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Human Immunodeficiency Virus (HIV) infection has nowadays become a chronic disease, due to the introduction of antiretroviral therapy (ART), which has improved both life expectancy and quality of life of patients with HIV but has also led to the emergence of previously unrecognized complications. Thromboembolic events constitute a serious and frequent comorbidity in patients with HIV. The thrombogenic potential of HIV infection is multifactorial and is attributed to persistent chronic inflammation, endothelial dysfunction and ART itself, mainly through the resulting metabolic alterations. Co‑infections and gut microbe translocation observed in patients with HIV, also maintain the inflammatory prothrombotic microenvironment. Individuals with HIV are at higher risk for venous thromboembolism and cardiovascular disease, compared with general population. Among patients with HIV, those receiving specific ART regimens have a significant higher risk for myocardial infraction. HIV infection is also involved in other coagulation disorders, such as heparin‑induced thrombocytopenia and thrombotic thrombocytopenic purpura. Therapeutic choices do not differ from individuals without HIV but should be cautiously administered due to drug interactions. Further studies are required in order to fully understand the pathophysiological mechanisms involved and develop new treatment options for patients with HIV.
View Figures
View References

Related Articles

Journal Cover

July-2025
Volume 23 Issue 1

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Dryllis G, Vasilopoulou M, Politou M, Gerogkiokas A, Pittaras T, Zoumpourlis V, Spandidos DA and Gialeraki A: Thrombotic and cardiovascular events in HIV infection (Review). Biomed Rep 23: 122, 2025.
APA
Dryllis, G., Vasilopoulou, M., Politou, M., Gerogkiokas, A., Pittaras, T., Zoumpourlis, V. ... Gialeraki, A. (2025). Thrombotic and cardiovascular events in HIV infection (Review). Biomedical Reports, 23, 122. https://doi.org/10.3892/br.2025.2000
MLA
Dryllis, G., Vasilopoulou, M., Politou, M., Gerogkiokas, A., Pittaras, T., Zoumpourlis, V., Spandidos, D. A., Gialeraki, A."Thrombotic and cardiovascular events in HIV infection (Review)". Biomedical Reports 23.1 (2025): 122.
Chicago
Dryllis, G., Vasilopoulou, M., Politou, M., Gerogkiokas, A., Pittaras, T., Zoumpourlis, V., Spandidos, D. A., Gialeraki, A."Thrombotic and cardiovascular events in HIV infection (Review)". Biomedical Reports 23, no. 1 (2025): 122. https://doi.org/10.3892/br.2025.2000